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Although substantial attention has been given
to the risks for the developing fetus from circu-
lating lead in maternal blood, much less con-
sideration has been given to the presence of
lead in breast milk. There are no clear guide-
lines regarding breast-feeding to provide coun-
seling to women with elevated blood or bone
lead levels (Sinks and Jackson 1999). Previous
research has shown that maternal bone lead
stores, accumulated from past environmental
exposures, are mobilized to a marked degree
during pregnancy and lactation (Gulson et al.
1997 1998b; Hernández-Avila et al. 1996;
Hertz-Picciotto et al. 2000; Hu et al. 1996;
Rothenberg et al. 2000). Breast-feeding prac-
tices and maternal bone lead levels have been
shown to be important predictors of maternal
blood lead levels over the course of lactation
(Téllez-Rojo et al. 2002). However, there is
less information available about the transfer of
lead to breast milk.
Lactation requires a substantial redistribu-
tion of maternal calcium that is marked by
mobilization of calcium from bone stores
(Sowers 1996). It is estimated that up to 5% of
bone mass is mobilized during lactation
(Hayslip et al. 1989; Sowers 1996); thus, lead
accumulated in bone from past exposures may
be released into blood and excreted into breast
milk. Generally, there is a low potential for
transfer of lead through milk when current
maternal exposure levels are low. However,
because > 90% of lead in the adult human
body is stored in bone (Barry 1975; Barry and
Mossman 1970), the possibility exists for sig-
niﬁcant redistribution of cumulative lead stores
from bone into plasma and subsequently into
breast milk during periods of heightened
bone turnover (e.g., pregnancy and lactation;
Silbergeld 1991). This phenomenon consti-
tutes a potential public health problem in areas
where environmental lead exposure is continu-
ing as well as in areas where environmental
lead exposure has recently declined.
Studies of lead in human breast milk have
found concentrations ranging over three orders
of magnitude from < 1 to > 100 µg/L (ppb;
Gulson et al. 1998a; Namihira et al. 1993).
These differences in lead levels are probably
attributable in part to true differences in expo-
sure distributions across populations and over
time. Methodologic factors that may affect the
reported results include the high potential for
contamination of samples, inaccuracy of labo-
ratory analytic methods, and study design
issues such as inconsistent sampling and analy-
sis protocols, incomplete reporting of sampling
methods, nonrepresentative sampling (geo-
graphic, age, parity), timing and duration of
sampling, and small numbers of study subjects
(LaKind et al. 2001).
Breast milk lead levels have been found to
be higher in urban compared to rural popu-
lations (Ong et al. 1985); however, it is not
possible to distinguish how much of these ele-
vations derives from ongoing environmental
exposure as opposed to mobilization of bone
lead stores. Some investigators have found that
lead levels in breast milk were higher than lev-
els in plasma (Wolff 1983). Bonithon-Kopp
et al. (1986) found that women > 30 years of
age had significantly higher levels of breast
milk lead than did women between 20 and
30 years of age. Because bone accumulates lead
with age, the implication was that increased
bone lead levels lead to increased breast milk
lead levels during lactation.
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Despite the many well-recognized beneﬁts of breast-feeding for both mothers and infants, detectable
levels of lead in breast milk have been documented in population studies of women with no current
environmental or occupational exposures. Mobilization of maternal bone lead stores has been sug-
gested as a potential endogenous source of lead in breast milk. We measured lead in breast milk to
quantify the relation between maternal blood and bone lead levels and breast-feeding status (exclusive
vs. partial) among 310 lactating women in Mexico City, Mexico, at 1 month postpartum. Umbilical
cord and maternal blood samples were collected at delivery. Maternal breast milk, blood, and bone
lead levels were obtained at 1 month postpartum. Levels of lead in breast milk ranged from 0.21 to
8.02 µg/L (ppb), with a geometric mean (GM) of 1.1 µg/L; blood lead ranged from 1.8 to 29.9 µg/dL
(GM = 8.4 µg/dL); bone lead ranged from < 1 to 67.2 µg/g bone mineral (patella) and from < 1 to
76.6 µg/g bone mineral (tibia) at 1 month postpartum. Breast milk lead was signiﬁcantly correlated
with umbilical cord lead [Spearman correlation coefﬁcient (rS)=   0.36, p < 0.0001] and maternal
blood lead (rS = 0.38, p < 0.0001) at delivery and with maternal blood lead (rS = 0.42, p < 0.0001) and
patella lead (rS = 0.15, p < 0.01) at 1 month postpartum. Mother’s age, years living in Mexico City,
and use of lead-glazed ceramics, all predictive of cumulative lead exposure, were not signiﬁcant predic-
tors of breast milk lead levels. Adjusting for parity, daily dietary calcium intake (milligrams), infant
weight change (grams), and breast-feeding status (exclusive or partial lactation), the estimated effect of
an interquartile range (IQR) increase in blood lead (5.0 µg/dL) was associated with a 33% increase in
breast milk lead [95% conﬁdence interval (CI), 24 to 43%], whereas an IQR increase in patella lead
(20 µg/g) was associated with a 14% increase in breast milk lead (95% CI, 5 to 25%). An IQR
increase in tibia lead (12.0 µg/g) was associated with a 5% increase in breast milk lead (95% CI, –3%
to 14%). Our results indicate that even among a population of women with relatively high lifetime
exposure to lead, levels of lead in breast milk are low, inﬂuenced both by current lead exposure and by
redistribution of bone lead accumulated from past environmental exposures. Key words: blood lead,
breast milk lead, breast-feeding, KXRF bone lead, lactation. Environ Health Perspect 112:926–931
(2004). doi:10.1289/ehp.6615 available via http://dx.doi.org/ [Online 7 April 2004]By examining the lead isotopic ratios in a
small number of postpartum recent immi-
grants to Australia (and postpartum Australian
controls), Gulson et al. (1998a) concluded that
the major sources of lead in breast milk are
from maternal bone and diet. In addition, they
found that the mobilization of lead from bone
during lactation continued postpartum for up
to 6 months and was larger than that experi-
enced during pregnancy (Gulson et al. 1998b).
We measured breast milk lead levels in a
large cohort of lactating women in Mexico
City at 1 month postpartum and quantified
the relation to maternal blood and bone lead
levels and breast-feeding status (exclusive vs.
partial). We used a rigorous, well-validated
technique to collect, prepare, and analyze the
samples of breast milk in this study, thus
limiting the potential for contamination and
maximizing the percentage recovery of lead
from milk samples.
Materials and Methods
We conducted a cross-sectional study of
310 lactating women at 1 month postpartum.
Subjects were a subcohort of women recruited
for later participation in a randomized placebo-
controlled trial of calcium supplementation
during lactation. Informed consent, question-
naire information, and samples for the present
study were obtained before the initiation of
calcium supplementation. All participating
mothers received a detailed explanation of the
study and counseling on reduction of lead
exposure. The research protocol was approved
by the human subjects committees of the
National Institute of Public Health of Mexico,
Harvard School of Public Health, and the
participating hospitals.
Data collection methods have been
described in detail elsewhere (Hernández-Avila
et al. 2003). Between January 1994 and June
1995, 2,945 potential study participants were
interviewed at three maternity hospitals in
Mexico City. Of these, 1,398 were eligible for
the trial. Exclusion criteria included logistics
that would interfere with data collection, such
as living outside of Mexico City; physician’s
diagnosis of multiple fetuses, pre-eclampsia, or
pregnancy-related hypertension; psychiatric,
kidney, or cardiac disease; gestational diabetes;
history of repeated urinary infections; family
or personal history of kidney stone formation;
seizure disorder requiring daily medications;
and ingestion of corticosteroids or other fac-
tors that may modify calcium metabolism.
Women who gave birth to premature infants
(< 37 weeks) also were excluded.
Of the women identified as eligible, 629
(45%) agreed to participate in the study. These
women completed a baseline evaluation,
including questionnaires that assessed known
risk factors for environmental lead exposure,
including current and past use of lead-glazed
ceramics; occupational, residential, medical,
and reproductive histories; and information
about intended breast-feeding practices.
Maternal dietary intake was assessed at 1 month
postpartum using a self-administered, semi-
quantitative food-frequency questionnaire
designed to estimate usual dietary intake over
an extended period of time (over the course of
pregnancy) before completion of the question-
naire. The questionnaire was translated and val-
idated for use in Spanish-speaking populations
speciﬁcally for the Mexican adult population
(Hernández-Avila et al. 1998).
For women identified before delivery,
umbilical cord and maternal blood samples
were collected at the birth. At 1 month post-
partum (± 5 days), field personnel visited
study participants at home to obtain anthro-
pometric measurements and blood and breast
milk samples. Maternal bone lead was esti-
mated by K–X-ray fluorescence (KXRF) at
the research facility at the American British
Cowdray (ABC) Hospital. The present analy-
sis is limited to data from 310 subjects with
breast milk samples collected at 1 month
postpartum with adequate volume for analysis
remaining after the pilot phase of the study
investigating methods for improved digestion
procedures.
Blood lead. Blood lead measurements were
performed using graphite furnace atomic
absorption spectrophotometry (model 3000;
Perkin-Elmer, Norwalk, CT, USA) at the
ABC Hospital Trace Metal Laboratory accord-
ing to a technique described by Miller et al.
(1987). The laboratory participates in the
Centers for Disease Control and Prevention
blood lead proﬁciency testing program admin-
istered by the Wisconsin State Laboratory of
Hygiene (Madison, WI, USA), which pro-
vided external quality control (QC) specimens
varying from 2 to 88 µg/dL. Our laboratory
maintained acceptable precision and accuracy
over the study period [correlation = 0.98; mean
difference = 0.71 µg/dL; SD = 0.68].
Bone lead. We used a spot-source 109Cd
KXRF instrument constructed at Harvard
University and installed at the research facility
in Mexico City to measure maternal bone
lead. Thirty-minute in vivo measurements of
each subject’s mid-tibial shaft (representing
cortical bone) and patella (trabecular bone)
were obtained after each region had been
washed with a 50% solution of isopropyl
alcohol. The physical principles, technical
specifications, validation, and use of the
KXRF technique have been described in
detail elsewhere (Hu et al. 1991). In brief, the
instrument uses a cadmium γ-ray source to
provoke the emission of fluorescent photons
from target tissue that are then detected,
counted, and arrayed on a spectrum. A net
lead signal is determined after subtraction of
Compton background counts by a linear
least-squares algorithm. The lead ﬂuorescent
signal is then normalized to the elastic or coher-
ently scattered γ-ray signal, which arises pre-
dominantly from the calcium and phosphorus
present in bone mineral (units of measurement
in micrograms of lead per gram of bone min-
eral). The instrument also provides an esti-
mate of the uncertainty associated with each
measurement. For QC, we excluded bone
lead measurements with uncertainty estimates
that were > 10 and 15 µg Pb/g mineral bone
for tibia (n = 12) and patella (n = 38), respec-
tively, from the entire cohort of 629 women.
These high uncertainty measurements gener-
ally reflect excessive patient movement out-
side of the measurement field or excessive
thickness of overlaying tissue and do not
produce acceptable results.
Breast milk lead. Breast milk samples were
collected at 1 month postpartum from lactat-
ing women. Samples were obtained and ana-
lyzed using techniques to minimize potential
for environmental contamination and to deter-
mine lead concentrations in breast milk with a
high percentage of recovery. Before manually
expressing milk, the breast was washed with
deionized water that also was collected and
analyzed for lead contamination. Ten milli-
liters of milk was collected in preleached
polypropylene tubes. Samples were frozen,
shipped to the Channing Laboratory (Boston,
MA, USA), and stored at –30°C (Fisher
IsoTempPlus) until analysis.
In pilot work, three different digestion
procedures for trace lead analysis of human
breast milk were evaluated: a) ashing acid-
pretreated samples in a muffle furnace,
b)m icrowave digestion with nitric acid
(HNO3) using PAAR bombs—a microwave
acid digestion bomb used for the dissolution
of analytical samples (Anton Paar USA,
Ashland, VA, USA), and c) digestion with
HNO3 in a high-temperature high-pressure
asher (HPA; Anton Paar USA, Ashland, VA,
USA). Digestion with HNO3 in an HPA was
chosen as the preferred method because it gave
the most accurate and reproducible results with
very low blanks. All sample handling was
performed under a class-100 clean hood. QC
samples were included from National Institute
of Standards and Technology (NIST) standard
reference materials (SRMs) with certiﬁed lead
concentrations (NIST SRM 1549 nonfat milk
and NIST SRM 8439 whole milk powder).
Breast milk samples were mixed thor-
oughly for 15 min in an ultrasonic mixer
(sonicator) before aliquoting for the analysis.
A 2-g aliquot of breast milk, 0.5 g of isotope
dilution spike (a solution of 10 ng/mL NIST
SRM 983, 206Pb-enriched), and 1 mL HNO3
(Optima grade, Fisher Chemicals, Fairlawn,
NJ, USA) were digested in a sealed 35-mL
capacity quartz vessel in the HPA. Five such
vessels were inserted in an aluminum heater
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unit was pressurized with nitrogen under
high pressure (115–118 bar), and the samples
were heated at 230°C for 90 min under com-
puter control with a sequenced temperature–
time program using a modified method of
Amarasiriwardena et al. (1997). Two sets of
five samples were digested each day. Each
batch contained one method blank. After
digestion, samples were cooled to room tem-
perature, and the resulting solution was trans-
ferred to 15-mL plastic tubes and diluted to
15 mL with distilled deionized water.
Lead content in the samples was ana-
lyzed by isotope dilution–inductively coupled
plasma mass spectrometry (ID-ICPMS;
Sciex Elan 5000; Perkin-Elmer). A batch of
24 samples contained one blank, two QC
standards, one spiked sample, and one dupli-
cate sample. The limit of detection for lead
analysis in breast milk by HPA digestion and
ID-ICPMS is 0.1 ng/mL (ppb) milk. The
accuracy of spiked samples and QC standards
at this concentration level (1 ng/mL) is > 90%,
and precision of the measurement is < 5%
relative standard deviation (RSD). Sample
preparation was performed at University
Research Institute for Analytical Chemistry
(Amherst, MA, USA), and instrumental
analysis was performed at the Trace Metals
Laboratory of Harvard School of Public
Health.
Statistical analysis. Univariate and bivari-
ate summary statistics and distributional plots
were examined for all variables. Characteristics
of the participants with and without breast
milk lead levels available were compared using
Wilcoxon/chi-squared tests of equality of sam-
ple means/proportions. Breast milk lead levels
were highly positively skewed. Ten extreme
outliers were identiﬁed using the generalized
extreme studentized deviation many-outlier
procedure (Rosner 1983) and were excluded
from the multivariate regression analyses. The
log(base e)-transformed values of the dependent
variable were used. Possible associations
between breast milk lead and the independent
variables were explored separately with bivariate
linear regression models. Spearman tests of cor-
relation were used, and correlation coefﬁcients
with p-values are reported. Nonparametric
smoothing (Lowess; bandwidth = 0.75) was
used to describe the associations between the
different lead biomarkers. Multiple linear
regression models were used to describe the
relationships between breast milk and the
covariates of interest, which were determined
a priori based on biologic considerations.
Parity, daily dietary calcium intake (milli-
grams), breast-feeding status (exclusive vs. par-
tial), and infant weight change (as a surrogate
for the amount of breast milk consumed) were
included along with each of the lead exposure
variables in separate models. Because of the dif-
ferent units of measurement for the blood and
bone lead biomarkers, direct comparison of the
regression coefﬁcients is not possible. To com-
pare the effect estimates for each of the maternal
lead biomarkers on breast milk lead, we esti-
mated the effect of interquartile range (IQR)
increase in the maternal lead biomarker on log
breast milk lead (µg/L) at 1 month postpartum,
expressed as percent change with 95% conﬁ-
dence intervals (95% CIs). All statistical analyses
were performed using Statistical Analysis System
(SAS) software (release 8.01; SAS Institute, Inc.,
Cary, NC, USA) and S-PLUS (6.0 Professional
Edition for Windows; Insightful Corp., Seattle,
WA, USA).
Results
On average, women in our Mexico City
cohort (n = 629) were 24.5 years of age (range,
14–44 years) and had lived in Mexico City for
20.5 years (range, 0.5–44 years); 43% were
primiparous. Of the 358 women with prior
pregnancies, 32% (n = 116) had completed
12 or more months of total breast-feeding of
their previous infants. Women with breast
milk lead measurements available were more
likely to have been breast-feeding exclusively
at 1 month postpartum (p < 0.0001) and
reported more total months of breast-feeding
in previous pregnancies (p < 0.0432) than did
women in the cohort without breast milk sam-
ples available for analysis (Table 1). Because
early pilot work degraded the milk samples
provided by some individuals, subjects with
milk available for additional chemical analyses
tended to have provided larger volumes of
milk and therefore were more likely to
have been exclusively breast-feeding. In addi-
tion, they were more likely to be married
(p = 0.0038) and had a slightly higher average
estimated daily calcium intake (p = 0.005)
than women without breast milk lead levels
available.
Figure 1 shows the distribution of breast
milk lead concentrations (n = 310) at 1 month
postpartum. The breast milk lead levels were
highly positively skewed. Levels of lead in breast
milk ranged from 0.21 to 8.02 µg/L (ppb),
with a geometric mean (GM) of 1.1 µg/L.
Breast milk lead was significantly corre-
lated with maternal blood [Spearman correla-
tion coefficient (rS)=   0.42, p < 0.0001] and
maternal patella lead (rS = 0.15, p < 0.01) at
1 month postpartum (Figure 2). Breast milk
lead was also significantly correlated with
umbilical cord (rS = 0.36, p < 0.0001) and
Children’s Health | Ettinger et al.
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Table 1. Differences in subject characteristics between participants with (n = 310) and without (n = 319)
breast milk lead measurements available at 1 month postpartum.
With breast milk Without breast milk
Mean ± SD Mean ± SD
Subject characteristics No. (range) No. (range) p-Valuea
Age of mother (years) 308 24.4 ± 5.0 315 24.6 ± 5.3 0.58
(14–43) (15–44)
Years living in Mexico City 308 20.1 ± 8.7 315 20.9 ± 7.9 0.22
(0.5–40) (1–44)
No. of years of school 304 9.3 ± 3.1 310 9.4 ± 3.0 0.75
(1–18) (1–17)
Married (%) 308 70.1 315 59.1 0.004
No. of prior pregnanciesb 308 2.0 ± 1.2 315 2.0 ± 1.3 0.90
(1–7) (1–8)
Primiparity (%) 308 41.9 315 45.1 0.42
Previous lactation > 12 months (%) 310 21.6 319 15.4 0.04
Exclusive breast-feeding (%) 308 32.1 314 14.3 < 0.0001
Estimated daily calcium intake (mg) 309 1,138 ± 390 319 1,072 ± 414 0.04
(93–2,532) (108–2,751)
Current use of lead-glazed ceramics (%) 310 40.7 319 39.8 0.83
Past use of lead-glazed ceramics (%) 308 76.6 315 78.4 0.59
Current smoking or during pregnancy (%) 310 6.1 319 7.5 0.49
Maternal blood lead (µg/dL) 310 9.3 ± 4.4 319 9.3 ± 4.9 0.98
(1.8–29.9) (2.3–60.1)
Maternal patella lead (µg/g bone mineral)c 294 14.5 ± 14.9 289 15.2 ± 16.1 0.58
(< 1–67.2) (< 1–85.9)
Maternal tibia lead (µg/g bone mineral)c 303 9.6 ± 10.1 306 10.5 ± 10.2 0.31
(< 1–76.5) (< 1–51.0)
ap-Value from t-test of equality of two sample population means or chi-square test of equality of two sample proportions.
bIncluding the index pregnancy (primiparous women = 43.1%). cIncludes measurements with negative values: patella (n = 134),
tibia (n= 99).
Figure 1. Distribution of breast milk lead levels



















> 4.0maternal blood (rS = 0.38, p < 0.0001) lead at
delivery. Figure 3 displays a plot of maternal
blood lead (µg/L) by the ratio of breast milk
lead to maternal blood lead (× 100) at 1 month
postpartum. Breast milk lead expressed as per-
centage of maternal blood lead ranged from
0.4 to 9.2% (mean = 1.6%, SD = 1.2%).
Differences in lead biomarkers by mater-
nal characteristics at 1 month postpartum are
shown in Table 2. Breast milk lead levels
(mean micrograms per liter ± SD) were simi-
lar among women who reported practicing
exclusive breast-feeding (1.38 ± 1.10) com-
pared with women who practiced partial lac-
tation (1.35 ± 1.09). The older women had
breast milk lead levels (1.11 ± 0.65) lower
than those in the younger age category (1.20
± 0.83) and lower than women in the 20–30
year age range (1.44 ± 1.19), who comprised
most participants. As expected, both patella
and tibia bone lead levels increased with age.
Mean breast milk lead levels were lower for
primiparous women (1.34 ± 1.12) than for
women with one previous pregnancy (1.42 ±
1.14) but lower still for women with two
or more previous pregnancies (1.30 ± 0.98),
although these differences were not statisti-
cally signiﬁcant. For women who had breast-
fed previously for 12 months or more (1.31 ±
1.27), breast milk lead levels were slightly
lower than for those women who had breast-
fed previously for less than 12 months (1.38 ±
0.90) or not at all (1.38 ± 1.22), although
these differences were also not statistically sig-
niﬁcant. Women who reported daily intake of
calcium < 1,000 mg had higher, though not
signiﬁcantly different (p = 0.23), breast milk
lead levels (1.45 ± 1.19) than did those who
received more adequate amounts of calcium
(≥ 1,000 mg) in their diets (1.30 ± 1.02).
Significant differences in breast milk, blood,
and patella lead levels were observed between
women who reported current use of lead-
glazed ceramics and those who did not use
leaded ceramics at the time of the interview.
Among women who reported current use of
lead-glazed ceramics, breast milk lead levels
averaged 1.53 ± 1.17 compared with 1.26 ±
1.03 for those who did not use leaded ceramics
(p = 0.03).
Mother’s age, years living in Mexico City,
and use of lead-glazed ceramics, all predictive of
cumulative lead exposure, were not signiﬁcant
bivariate predictors of breast milk lead levels.
Maternal blood lead at delivery (β = 0.0608,
p < 0.0001) and at 1 month postpartum (β =
0.0588, p < 0.0001) were signiﬁcant predictors
of breast milk lead at 1 month postpartum.
After adjusting for infant weight change
(grams), parity, daily dietary calcium intake,
and breast-feeding status (exclusive or partial
lactation), patella lead was a signiﬁcant predic-
tor of breast milk lead (β = 0.0068, p = 0.003).
However, patella lead was no longer signiﬁcant
when we controlled for maternal blood lead
because the effect of patella bone lead is medi-
ated through blood lead. Maternal blood lead
at delivery (β = 0.0396, p < 0.0001) and at
1 month postpartum (β = 0.0363, p < 0.0001)
both remained signiﬁcant independent deter-
minants of lead in breast milk in the multivari-
ate analyses. The estimated effect of an IQR
increase in blood lead (5 µg/dL) was associated
with a 33% increase in breast milk lead (95%
CI, 24 to 43%), whereas an IQR increase in
patella lead (20 µg/g) was associated with a
14% increase in breast milk lead (95% CI, 5 to
25%; Table 3). An IQR increase in tibia lead
(12 µg/g) was associated with a 5% increase in
breast milk lead (95% CI, –3 to 14%).
Discussion
Despite the many well-recognized beneﬁts of
breast-feeding for both mothers and infants,
detectable levels of lead in breast milk have
been documented in population studies of
women with no current environmental or
occupational exposures (Abadin et al. 1997).
Because lead accumulates in bone, women
who were chronically exposed to environmen-
tal lead during infancy and adolescence may
have a significant bone lead burden when
they reach reproductive age. We have demon-
strated here that maternal blood and bone
lead levels are important determinants of lead
in breast milk at 1 month postpartum. Breast
milk lead levels are inﬂuenced both by current
environmental exposures and by the redistrib-
ution of previously accumulated maternal
lead due to bone resorption associated with
pregnancy and lactation.
Osterloh and Kelly (1999) assessed lactating
women prospectively to study the effect of lac-
tational bone loss on blood lead concentrations
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Figure 2. Smooth scatterplots (Lowess; bandwidth = 0.75) of breast milk lead by maternal lead biomarkers at 1 month postpartum: (A) blood lead; (B) patella lead;
(C) tibia lead. Breast milk lead levels log(base-e) transformed.
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Children’s Health | Breast milk lead in relation to maternal blood and boneand found that bone density losses averaged
2.5% at the vertebral spine and almost 1% at
the femoral neck. The total number of breast-
feedings was the only signiﬁcant independent
predictor of ﬁnal bone density apart from the
initial bone density. No changes in blood lead
concentration, however, were observed after
2 weeks postpartum. In a study of community
volunteers, Kosnett et al. (1994) found that
women with a history of breast-feeding had
lower age-adjusted tibia bone lead levels than
did those without a history of lactation, suggest-
ing that lactation depletes maternal bone lead.
Moline et al. (2000) noted a signiﬁcant inverse
relationship between months of lactation and
age-adjusted calcaneus lead among 24 lactating
women in Mexico City. Hernández-Avila et al.
(1996) demonstrated that patellar lead is a
main determinant of circulating blood lead dur-
ing lactation. A 34-µg/g increase in patella lead
(from the medians of the lowest to the highest
quartiles) was associated with an increase in
blood lead of 2.4 µg/dL. Sowers et al. (2002)
found direct evidence of bone loss among
breast-feeding mothers compared with bottle-
feeders by examining changes in bone mineral
density and serum osteocalcin levels in relation
to maternal blood and breast milk lead levels.
Our results indicate, however, that even
among a population of women with relatively
high cumulative lifetime exposures to lead, as
evidenced by their bone lead levels, levels of
lead in breast milk are low. Previous results
from this cohort showed that breast-feeding
practices and maternal bone lead levels were
important predictors of maternal blood lead
levels over the course of lactation (Téllez-Rojo
et al. 2002). Here we present levels of lead in
breast milk having used a rigorous, well-vali-
dated technique to collect, prepare, and analyze
the samples. Breast milk lead levels from previ-
ous published studies with extremely high val-
ues should be reviewed with caution because of
the high potential for contamination and inac-
curacy of the laboratory analytic methods.
Documented sources of lead contamina-
tion in breast milk include use of lead acetate
ointment (Knowles 1974), lead in nipple
shields (Knowles 1974; Newman 1997), and
foil from alcohol wipes used in sample col-
lection (Hu et al. 1996). Because the concen-
trations of lead in breast milk are low, the
inﬂuence of environmental contamination is
high (Smith et al. 1998).
Gulson et al. (1998a) proposed using the
comparison of ratios expressed as percentage of
lead concentrations in breast milk to whole
blood as a method to verify the results, suggest-
ing that data with a ratio of > 15% should be
treated with caution. High lead concentrations
in breast milk relative to blood lead concen-
trations would thus be an indicator of con-
tamination during sample collection and/or
laboratory analysis. In all of the 310 sample
pairs in our study, ratios of breast milk to
whole blood lead levels were < 15%.
In addition, measurement of lead in breast
milk is complicated by the fat content of
human milk. The fat content of human breast
milk changes during feeding and over the
course of lactation (Sim and McNeil 1992).
Precise and accurate analysis is challenging
because of difﬁculty in identifying a method
that will digest samples with 100% efﬁciency.
Our group has developed these techniques both
to obtain breast milk samples that minimize
potential for contamination and to determine
lead concentrations in breast milk with a high
percentage of recovery (Amarasiriwardena C,
Hu H, unpublished data). In the technique
used for this analysis, we determined the parti-
tioning of lead between the acid soluble and
“fat” residue. Lead concentrations in the fat
portion alone were close to the detection limit,
indicating a high recovery of lead in the milk.
This is a cross-sectional analysis and cannot
evaluate changes in breast milk and bone lead
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Table 2. Lead concentrations by subject characteristics at 1 month postpartum (n = 310).
Mean maternal lead concentration ± SD
Breast milk Blood Patella Tibia
Subject characteristic No. (µg/L) (µg/dL) (µg/g) (µg/g)
Mother’s age (years)a
< 20 49 1.20 ± 0.83 9.4 ± 4.5 11.6 ± 12.8 7.4 ± 7.1
20–30 220 1.44 ± 1.19 9.3 ± 4.5 14.7 ± 15.2 9.6 ± 10.7
> 30 39 1.11 ± 0.65 9.0 ± 3.9 17.6 ± 15.4 12.4 ± 9.6
Years spent living in Mexico Cityb
< 5 26 0.99 ± 0.43 7.6 ± 3.1 10.5 ± 11.7* 5.1 ± 8.0*
5–20 82 1.29 ± 1.03 8.9 ± 4.6 11.2 ± 13.5 7.7 ± 10.6
> 20 200 1.43 ± 1.17 9.7 ± 4.5 16.5 ± 15.5 11.0 ± 10.0
No. of prior pregnanciesc
0 129 1.34 ± 1.12 9.5 ± 4.7 13.7 ± 13.6 9.2 ± 9.2
1 104 1.42 ± 1.14 8.5 ± 3.8 14.3 ± 16.1 9.0 ± 9.7
≥ 27 51 .30 ± 0.98 10.0 ± 4.7 16.6 ± 15.2 11.2 ± 12.1
Previous lactation
None 104 1.38 ± 1.22 9.6 ± 4.8 14.0 ± 13.5 9.5 ± 9.6
< 12 months 139 1.39 ± 0.90 9.3 ± 4.2 14.9 ± 15.9 9.9 ± 10.8
≥ 12 months 67 1.31 ± 1.27 8.5 ± 4.3 14.5 ± 15.1 9.2 ± 9.4
Reported breast-feeding practiced
Exclusive 99 1.38 ± 1.10 9.5 ± 5.0 14.8 ± 13.2 9.7 ± 9.3
Partial 209 1.35 ± 1.09 9.2 ± 4.1 14.5 ± 15.7 9.6 ± 10.5
Current use of lead-glazed ceramics
Yes 126 1.53 ± 1.17* 10.8 ± 5.2* 17.0 ± 15.1* 10.8 ± 12.0
No 184 1.26 ± 1.03 8.2 ± 3.4 12.8 ± 14.5 8.8 ± 8.5
Past use of lead-glazed ceramicse
Yes 236 1.40 ± 1.11 9.3 ± 4.3 14.5 ± 15.2 10.1 ± 10.5
No 72 1.23 ± 1.03 9.3 ± 4.8 14.7 ± 14.0 8.3 ± 8.8
Dietary calcium intakef
< 1,000 mg 138 1.45 ± 1.19 9.5 ± 4.6 13.4 ± 15.3 10.3 ± 10.2
≥ 1,000 mg 171 1.30 ± 1.02 9.0 ± 4.3 15.2 ± 14.5 9.1 ± 10.1
aTwo subjects missing information on mother’s age. bTwo subjects missing information on years spent living in Mexico
City. cTwo subjects missing information on number of prior pregnancies. dTwo subjects missing information on reported
breast-feeding practice. eTwo subjects missing information on past use of lead-glazed ceramics. fOne subject missing
information on dietary calcium intake. *Signiﬁcantly different at 0.05 level by analysis of variance.
Table 3. Estimated effecta of IQR increase in maternal lead biomarker on log breast milk leadb (µg/L) at 1 month postpartum expressed as percent change (95% CI).
Model
Predictor variable(s) A B C D E F G
Blood lead at delivery 36 — — — 22 — —
IQR = 5 µg/dL (26 to 46) (12 to 33)
Blood lead at 1 month postpartum — 33 — — 20 33 34
IQR = 5 µg/dL (24 to 43) (10 to 30) (23 to 43) (25 to 44)
Patella lead at 1 month postpartum — — 14 — — 3 —
IQR = 20 µg/g (5 to 25) (–5 to 13)
Tibia lead at 1 month postpartum — — — 5 –2
IQR = 12 µg/g (–3 to 14) — — (–9 to 5)
aAdjusted for estimated daily calcium intake (milligrams); infant weight change (grams); number of prior pregnancies; and breast-feeding practice (exclusive vs. partial lactation).
bBreast milk lead levels log transformed.levels over the course of lactation. It will also be
important to determine whether the degree of
this inﬂuence changes over the course of lac-
tation. Factors that may modify levels of chemi-
cals in breast milk were only partially controlled
and include fat content of breast milk, extent
and duration of breast-feeding, maternal age
and body weight, duration of lactation, parity,
multiple pregnancies, race, socioeconomic sta-
tus, season, and maternal nutrition and hor-
mone levels. However, this study represents the
largest epidemiologic study of lead in breast
milk in relation to maternal lead biomarkers
and is, to our knowledge, the only study using
in vivo measurement of lead in bone.
Given that bone lead has a half-life of years
to decades, infants will continue to be at risk for
exposure from maternal bone lead stores long
after environmental sources of lead have been
abated. The overall decline of ambient environ-
mental concentrations of lead highlights the
importance of bone lead as an endogenous
source of exposure. However, given the low lev-
els of lead in breast milk demonstrated here, the
contribution from foods and beverages used as
alternatives to or in combination with breast
milk may be similar to or greater than that of
breast milk. All levels were below the current
U.S. Environmental Protection Agency (EPA)
maximum contaminant level for lead in water
(15 ppb; U.S. EPA 1991), which is relevant
because the alternative to breast-feeding, infant
formula, is often prepared with tap water.
Better understanding of neonatal exposure,
including kinetics in the lactating mother and
in the newborn, and knowledge about alterna-
tive dietary sources of lead are needed for risk
assessment. Estimating the potential lead dose
to infants from breast milk requires informa-
tion on the quantity of breast milk consumed
per day and the duration over which breast-
feeding occurs (U.S. EPA 1997). Additional
information on the lead content of dietary
alternatives should be investigated in compari-
son with breast milk levels in a speciﬁc popula-
tion, and interactions with other nutritional
factors should also be considered. Despite the
potential for lead exposure, breast milk remains
the best and most complete nutritional source
for young infants, especially given the low
levels of lead in breast milk in this group of
mothers with relatively high cumulative life-
time exposures to lead.
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